SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001694665-23-000115
Filing Date
2023-07-12
Accepted
2023-07-12 07:55:14
Documents
15
Period of Report
2023-07-11
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K evlo-20230711.htm   iXBRL 8-K 30694
2 EX-10.1 exhibit101-2023pipexrraxfi.htm EX-10.1 152502
3 EX-99.1 exhibit991-71223pressrelea.htm EX-99.1 14702
7 evlo-20230711_g1.jpg GRAPHIC 7885
  Complete submission text file 0001694665-23-000115.txt   380764

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT evlo-20230711.xsd EX-101.SCH 1905
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT evlo-20230711_lab.xml EX-101.LAB 24833
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT evlo-20230711_pre.xml EX-101.PRE 13049
9 EXTRACTED XBRL INSTANCE DOCUMENT evlo-20230711_htm.xml XML 2814
Mailing Address 620 MEMORIAL DRIVE SUITE 500 CAMBRIDGE MA 02139
Business Address 620 MEMORIAL DRIVE SUITE 500 CAMBRIDGE MA 02139 617-577-0300
Evelo Biosciences, Inc. (Filer) CIK: 0001694665 (see all company filings)

IRS No.: 465594527 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38473 | Film No.: 231083273
SIC: 2834 Pharmaceutical Preparations